Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations

M. W. Nagel, K. J. Wiersema, C. C. Doyle, J. P. Mitchell, R. Sharpe (London, Canada; Nottingham, United Kingdom)

Source: Annual Congress 2006 - Therapy in childhood asthma II
Session: Therapy in childhood asthma II
Session type: Thematic Poster Session
Number: 4097
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. W. Nagel, K. J. Wiersema, C. C. Doyle, J. P. Mitchell, R. Sharpe (London, Canada; Nottingham, United Kingdom). Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations. Eur Respir J 2006; 28: Suppl. 50, 4097

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery
Source: Eur Respir J 2001; 18: Suppl. 33, 494s
Year: 2001

Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use.
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


New anti-static youth valved holding chamber (VHC) can be used out-of-package and deliver β2-agonist medication effectively
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


In vitro delivery of an HFA-based corticosteroid by pediatric and adult valved holding chambers (VHC): effect of inhalation flow rate
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

A visual indicator for inhalation from a valved holding chamber (VHC) is an aid in delivery of inhaled medication to infants and small children via facemask
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Patient centered development of a new valved holding chamber (VHC) designed specifically for on-the-go use
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Medication delivery via infant and child valved holding chambers (VHCs) with facemask is aided with inhalation flow indicator
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008


Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018




Novel non-electrostatic valved holding chamber (VHC) has comparable in vitro performance for delivery of beta-2 agonist as similar-sized, pre-washed but non-conducting VHC
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006

Medication delivery testing of valved holding chambers (VHCs) with facemask for infant use by means of a model infant face
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016

Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

In vitro performance of a new non-electrostatic, transparent valved holding chamber (VHC) for the poorly coordinated patient
Source: Eur Respir J 2004; 24: Suppl. 48, 380s
Year: 2004

In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

The impact of different valved holding chambers (VHCs) on lung drug delivery: using functional respiratory imaging (FRI) and a single metered dose inhaler (MDI) type
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020




Valved holding chamber drug delivery is dependent on breathing pattern and device design
Source: ERJ Open Res, 5 (1) 00158-2018; 10.1183/23120541.00158-2018
Year: 2019



A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations
Source: Eur Respir J 2005; 26: Suppl. 49, 340s
Year: 2005